TY - JOUR
T1 - Association of lambert-eaton myasthenic syndrome and first episode psychosis
T2 - a case report
AU - Siopa, Carlos
AU - Cordeiro, Catarina
AU - Moura, Bernardo Melo
N1 - Publisher Copyright:
Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2025/1/22
Y1 - 2025/1/22
N2 - Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune neuromuscular junction disorder characterized by proximal weakness, autonomic dysfunction, and areflexia associated with antibodies against voltage-gated calcium channels (VGCCs). Psychotic symptoms can occur in many autoimmune neurological disorders but they have rarely been observed in myasthenic syndromes. We report the case of a 21-year-old woman with primary autoimmune LEMS due to anti-VGCC antibodies subtype P/Q, who developed psychotic symptoms 3 years after the onset of motor symptoms. These symptoms decreased after every cycle of monthly intravenous immunoglobulin therapy. Different causes of reversible psychosis were excluded, such as autoimmune encephalitis. Due to a worsening of the patient's muscle strength, and the psychotic episodes, the patient received several treatments including an admission to a neurology unit. To our knowledge, this is the first described case of psychotic symptoms associated with LEMS. We speculate that VGCC antibodies could have a role in the development of mental symptoms, although additional hypotheses are also discussed.
AB - Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune neuromuscular junction disorder characterized by proximal weakness, autonomic dysfunction, and areflexia associated with antibodies against voltage-gated calcium channels (VGCCs). Psychotic symptoms can occur in many autoimmune neurological disorders but they have rarely been observed in myasthenic syndromes. We report the case of a 21-year-old woman with primary autoimmune LEMS due to anti-VGCC antibodies subtype P/Q, who developed psychotic symptoms 3 years after the onset of motor symptoms. These symptoms decreased after every cycle of monthly intravenous immunoglobulin therapy. Different causes of reversible psychosis were excluded, such as autoimmune encephalitis. Due to a worsening of the patient's muscle strength, and the psychotic episodes, the patient received several treatments including an admission to a neurology unit. To our knowledge, this is the first described case of psychotic symptoms associated with LEMS. We speculate that VGCC antibodies could have a role in the development of mental symptoms, although additional hypotheses are also discussed.
KW - Autoimmune encephalitis psychosis
KW - Autoimmune neuropsychiatry
KW - Intravenous immunoglobulin neuropsychiatric treatment
KW - Lambert-Eaton myasthenic syndrome
KW - Psychosis
KW - Voltage-gated calcium channel antibodies in psychiatric autoimmunity
UR - http://www.scopus.com/inward/record.url?scp=85216537768&partnerID=8YFLogxK
U2 - 10.1097/PRA.0000000000000837
DO - 10.1097/PRA.0000000000000837
M3 - Article
C2 - 39836681
AN - SCOPUS:85216537768
SN - 1527-4160
VL - 31
SP - 42
EP - 45
JO - Journal of Psychiatric Practice
JF - Journal of Psychiatric Practice
IS - 1
ER -